Steroids and childhood encephalitis

Pediatric Infectious Disease Journal

Volumn 31, Issue 7, 2012, Pages 759-760

  Esposito, Susanna ^a   Picciolli, Irene ^a   Semino, Margherita ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; DEXAMETHASONE; METHYLPREDNISOLONE; MYELIN; MYELIN PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PREDNISOLONE; PROSTAGLANDIN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ACUTE INFECTIOUS ENCEPHALITIS; ANTIVIRAL THERAPY; BLOOD BRAIN BARRIER; BRAIN BIOPSY; CENTRAL NERVOUS SYSTEM; CHILDHOOD DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; ENCEPHALITIS; ENTEROVIRUS; HEALTH PROGRAM; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; JAPANESE ENCEPHALITIS VIRUS; MEASLES VIRUS; MUMPS VIRUS; MYCOPLASMA PNEUMONIAE; NEISSERIA MENINGITIDIS; NERVE CELL NECROSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RUBELLA VIRUS; SPINAL CORD; STEROID THERAPY; STREPTOCOCCUS PNEUMONIAE; TICK BORNE ENCEPHALITIS FLAVIVIRUS; TREATMENT DURATION; VACCINATION; VARICELLA ZOSTER VIRUS; VIRAL CLEARANCE; VIRUS REACTIVATION; VIRUS REPLICATION;

ANTI-INFLAMMATORY AGENTS; ENCEPHALITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; STEROIDS; TREATMENT OUTCOME;

EID: 84862745114     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31825b129b     Document Type: Review

References (19)

1. Czock D, Keller F, Rasche FM, et al. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44:61-98. (Pubitemid 40096038)
2. Tunkel AR, Glaser CA, Bloch KC, et al. Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47:303-327. (Pubitemid 352013512)
3. Sonneville R, Klein IF, Wolff M. Update on investigation and management of postinfectious encephalitis. Curr Opin Neurol. 2010;23: 300-304.
4. Granerod J, Ambrose HE, Davies NW, et al.; UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10:835-844.
5. Meyding-Lamadé U, Seyfer S, Haas J, et al. Experimental herpes simplex virus encephalitis: inhibition of the expression of inducible nitric oxide synthase in mouse brain tissue. Neurosci Lett. 2002;318:21-24. (Pubitemid 34084956)
6. Meyding-Lamadé UK, Oberlinner C, Rau PR, et al. Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol. 2003;9:118-125. (Pubitemid 36378109)
7. Sergerie Y, Boivin G, Gosselin D, et al. Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice. J Infect Dis. 2007;195:817-825. (Pubitemid 46363926)
8. Kamei S, Sekizawa T, Shiota H, et al. Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatr. 2005;76:1544-1549. (Pubitemid 41531703)
9. Yamamoto K, Chiba HO, Ishitobi M, et al. Acute encephalopathy with bilateral striatal necrosis: favourable response to corticosteroid therapy. Eur J Paediatr Neurol. 1997;1:41-45. (Pubitemid 127703428)
10. Musallam B, Matoth I, Wolf DG, et al. Steroids for deteriorating herpes simplex virus encephalitis. Pediatr Neurol. 2007;37:229-232. (Pubitemid 47334874)
11. Martinez-Torres F, Menon S, Pritsch M, et al. GACHE Investigators. Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. BMC Neurol. 2008;8:40.
12. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, et al. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000;342:635-645. (Pubitemid 30118417)
13. Hoke CH Jr, Vaughn DW, Nisalak A, et al. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis. 1992;165:631-637.
14. Hynson JL, Kornberg AJ, Coleman LT, et al. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology. 2001;56:1308-1312. (Pubitemid 32455289)
15. Nishikawa M, Ichiyama T, Hayashi T, et al. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol. 1999;21:583-586. (Pubitemid 29366831)
16. Keegan M, Pineda AA, McClelland RL, et al. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002;58:143-146.
17. Leake JA, Albani S, Kao AS, et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J. 2004;23:756-764. (Pubitemid 39063291)
18. Menge T, Kieseier BC, Nessler S, et al. Acute disseminated encephalomyelitis: an acute hit against the brain. Curr Opin Neurol. 2007;20: 247-254. (Pubitemid 46743104)
19. Hemachudha T, Griffin DE, Giffels JJ, et al. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med. 1987;316: 369-374. (Pubitemid 17034261)